ReP USP - Resultado da busca

Artigo de periodico
Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer (2019)
Souza, Marília Cristina Oliveira; Marques, Maria Paula; Duarte, Geraldo; Lanchote, Vera Lúcia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FMRP, FCFRP
Assunto: ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Marília Cristina Oliveira et al. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, v. 164, p. 268-275, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2018.10.040. Acesso em: 03 jun. 2024.
APA
Souza, M. C. O., Marques, M. P., Duarte, G., & Lanchote, V. L. (2019). Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer. Journal of Pharmaceutical and Biomedical Analysis, 164, 268-275. doi:10.1016/j.jpba.2018.10.040
NLM
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Vancouver
Souza MCO, Marques MP, Duarte G, Lanchote VL. Analysis of bupivacaine enantiomers in plasma as total and unbound concentrations using LC-MS/MS:: application in a pharmacokinetic study of a parturient with placental transfer [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2019 ; 164 268-275.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jpba.2018.10.040
Artigo de periodico
Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women (2018)
Ribeiro, Rodrigo Metzker Pereira; Moreira, Fernanda de Lima; Moisés, Elaine Christine Dantas; Cavalli, Ricardo de Carvalho; Quintana, Silvana Maria; Lanchote, Vera Lúcia; Duarte, Geraldo
Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOLOGIA, ANTIRRETROVIRAIS, SANGUE, CORDÃO UMBILICAL, VÍRUS, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
RIBEIRO, Rodrigo Metzker Pereira et al. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, v. 84, n. 10, p. 2415-2421, 2018Tradução . . Disponível em: https://doi.org/10.1111/bcp.13700. Acesso em: 03 jun. 2024.
APA
Ribeiro, R. M. P., Moreira, F. de L., Moisés, E. C. D., Cavalli, R. de C., Quintana, S. M., Lanchote, V. L., & Duarte, G. (2018). Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women. British Journal of Clinical Pharmacology, 84( 10), 2415-2421. doi:10.1111/bcp.13700
NLM
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/bcp.13700
Vancouver
Ribeiro RMP, Moreira F de L, Moisés ECD, Cavalli R de C, Quintana SM, Lanchote VL, Duarte G. Lopinavir/ritonavir treatment increases the placental transfer of bupivacaine enantiomers in human immunodeficiency virus-infected pregnant women [Internet]. British Journal of Clinical Pharmacology. 2018 ; 84( 10): 2415-2421.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/bcp.13700
Tese (Doutorado)
Efeito do lúpus eritematoso sistêmico na atividade do transportador de influxo sinusoidal OATP1B1 avaliado com base na farmacocinética e farmacodinâmica da atorvastatina (2018)
Cestari, Roberta Natália; Lanchote, Vera Lúcia (Orientador)
Unidade: FCFRP
Subjects: LÚPUS ERITEMATOSO SISTÊMICO, FARMACOCINÉTICA, FARMACODINÂMICA, CITOCINAS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESTARI, Roberta Natália. Efeito do lúpus eritematoso sistêmico na atividade do transportador de influxo sinusoidal OATP1B1 avaliado com base na farmacocinética e farmacodinâmica da atorvastatina. 2018. Tese (Doutorado) – Universidade de São Paulo, Ribeirão Preto, 2018. Disponível em: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-24052019-161448/. Acesso em: 03 jun. 2024.
APA
Cestari, R. N. (2018). Efeito do lúpus eritematoso sistêmico na atividade do transportador de influxo sinusoidal OATP1B1 avaliado com base na farmacocinética e farmacodinâmica da atorvastatina (Tese (Doutorado). Universidade de São Paulo, Ribeirão Preto. Recuperado de http://www.teses.usp.br/teses/disponiveis/60/60134/tde-24052019-161448/
NLM
Cestari RN. Efeito do lúpus eritematoso sistêmico na atividade do transportador de influxo sinusoidal OATP1B1 avaliado com base na farmacocinética e farmacodinâmica da atorvastatina [Internet]. 2018 ;[citado 2024 jun. 03 ] Available from: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-24052019-161448/
Vancouver
Cestari RN. Efeito do lúpus eritematoso sistêmico na atividade do transportador de influxo sinusoidal OATP1B1 avaliado com base na farmacocinética e farmacodinâmica da atorvastatina [Internet]. 2018 ;[citado 2024 jun. 03 ] Available from: http://www.teses.usp.br/teses/disponiveis/60/60134/tde-24052019-161448/
Trabalho de evento-resumo
Effects of maternal obesity on the delivery outcome during labor induction with misoprostol (2017)
Filgueira, G.; Filgueira, O.; Carvalho, D.; Marques, M.; Rocha, A.; Moisés, Elaine Christine Dantas; Duarte, Geraldo; Lanchote, Vera Lúcia; Cavalli, Ricardo de Carvalho
Source: Abstracts. Conference titles: World Congress on Maternal Fetal Neonatal Medicine. Unidades: FMRP, FCFRP
Subjects: OBESIDADE, GRAVIDEZ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, G. et al. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. 2017, Anais.. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, 2017. . Acesso em: 03 jun. 2024.
APA
Filgueira, G., Filgueira, O., Carvalho, D., Marques, M., Rocha, A., Moisés, E. C. D., et al. (2017). Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. In Abstracts. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo.
NLM
Filgueira G, Filgueira O, Carvalho D, Marques M, Rocha A, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. Abstracts. 2017 ;[citado 2024 jun. 03 ]
Vancouver
Filgueira G, Filgueira O, Carvalho D, Marques M, Rocha A, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of maternal obesity on the delivery outcome during labor induction with misoprostol. Abstracts. 2017 ;[citado 2024 jun. 03 ]
Artigo de periodico
Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis (2017)
Castro, Francine Attié de; Simões, Belinda Pinto; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CITOCINAS, FÁRMACOS IMUNOSSUPRESSORES, ESCLEROSE MÚLTIPLA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 784-795, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.863. Acesso em: 03 jun. 2024.
APA
Castro, F. A. de, Simões, B. P., Coelho, E. B., & Lanchote, V. L. (2017). Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis. The Journal of Clinical Pharmacology, 57( 6), 784-795. doi:10.1002/jcph.863
NLM
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.863
Vancouver
Castro FA de, Simões BP, Coelho EB, Lanchote VL. Enantioselectivity in the metabolism of cyclophosphamide in patients with multiple or systemic sclerosis [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 784-795.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.863
Artigo de periodico
The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries (2017)
Costa, A. C. C.; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia; Correia, B. V.; Abumansur, Juliana Trench; Lauretti, Gabriela Rocha; Moraes, N. V. de
Source: European Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: FARMACOGENÉTICA, FARMACOCINÉTICA, POLIMORFISMO, BLOQUEIO NERVOSO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, A. C. C. et al. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, v. 73, n. 8, p. 957-963, 2017Tradução . . Disponível em: https://doi.org/10.1007/s00228-017-2243-1. Acesso em: 03 jun. 2024.
APA
Costa, A. C. C., Coelho, E. B., Lanchote, V. L., Correia, B. V., Abumansur, J. T., Lauretti, G. R., & Moraes, N. V. de. (2017). The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries. European Journal of Clinical Pharmacology, 73( 8), 957-963. doi:10.1007/s00228-017-2243-1
NLM
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Vancouver
Costa ACC, Coelho EB, Lanchote VL, Correia BV, Abumansur JT, Lauretti GR, Moraes NV de. The SLCO1A2 -189_-188InsA polymorphism reduces clearance of rocuronium in patients submitted to elective surgeries [Internet]. European Journal of Clinical Pharmacology. 2017 ; 73( 8): 957-963.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00228-017-2243-1
Artigo de periodico
Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients (2017)
Nardotto, Glauco H. B; Lanchote, Vera Lúcia; Coelho, Eduardo Barbosa; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Subjects: FARMACOLOGIA, DIABETES MELLITUS, ANTAGONISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B et al. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, v. 109S, p. S108-S115, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.05.033. Acesso em: 03 jun. 2024.
APA
Nardotto, G. H. B., Lanchote, V. L., Coelho, E. B., & Della Pasqua, O. (2017). Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients. European Journal of Pharmaceutical Sciences, 109S, S108-S115. doi:10.1016/j.ejps.2017.05.033
NLM
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033
Vancouver
Nardotto GHB, Lanchote VL, Coelho EB, Della Pasqua O. Population pharmacokinetics of carvedilol enantiomers and their metabolites in healthy subjects and type-2 diabetes patients [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109S S108-S115.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.033
Artigo de periodico
Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac (2017)
Silva, Carolina de Miranda; Rocha, Adriana; Tozatto, Eduardo; Silva, Lucienir Maria da; Donadi, Eduardo Antônio; Costa, Teresa Dalla; Lanchote, Vera Lúcia; Schmidt, Stephan; Bulitta, Jürgen B.
Source: The AAPS Journal. Unidades: FCFRP, FMRP
Subjects: FARMACODINÂMICA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina de Miranda et al. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, v. 19, n. 6, p. 1814-1825, 2017Tradução . . Disponível em: https://doi.org/10.1208/s12248-017-0138-9. Acesso em: 03 jun. 2024.
APA
Silva, C. de M., Rocha, A., Tozatto, E., Silva, L. M. da, Donadi, E. A., Costa, T. D., et al. (2017). Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac. The AAPS Journal, 19( 6), 1814-1825. doi:10.1208/s12248-017-0138-9
NLM
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1208/s12248-017-0138-9
Vancouver
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Costa TD, Lanchote VL, Schmidt S, Bulitta JB. Development of an enantioselective and biomarker-informed translational population pharmacokinetic/pharmacodynamic model for etodolac [Internet]. The AAPS Journal. 2017 ; 19( 6): 1814-1825.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1208/s12248-017-0138-9
Artigo de periodico
Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women (2017)
Filgueira, Gabriela Campos de Oliveira; Filgueira, Osmany Alberto Silva; Carvalho, Daniela Miarelli; Marques, Maria Paula; Moisés, Elaine Christine Dantas; Duarte, Geraldo; Lanchote, Vera Lúcia; Cavalli, Ricardo de Carvalho
Source: British Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: HIPERTENSÃO, FARMACOCINÉTICA, GRAVIDEZ, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FILGUEIRA, Gabriela Campos de Oliveira et al. Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women. British Journal of Clinical Pharmacology, v. 83, n. 7, p. 1571-1579, 2017Tradução . . Disponível em: https://doi.org/10.1111/bcp.13226. Acesso em: 03 jun. 2024.
APA
Filgueira, G. C. de O., Filgueira, O. A. S., Carvalho, D. M., Marques, M. P., Moisés, E. C. D., Duarte, G., et al. (2017). Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women. British Journal of Clinical Pharmacology, 83( 7), 1571-1579. doi:10.1111/bcp.13226
NLM
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women [Internet]. British Journal of Clinical Pharmacology. 2017 ; 83( 7): 1571-1579.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/bcp.13226
Vancouver
Filgueira GC de O, Filgueira OAS, Carvalho DM, Marques MP, Moisés ECD, Duarte G, Lanchote VL, Cavalli R de C. Effects of type 2 diabetes mellitus on the pharmacokinetics and transplacental transfer of nifedipine in hypertensive pregnant women [Internet]. British Journal of Clinical Pharmacology. 2017 ; 83( 7): 1571-1579.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/bcp.13226
Artigo de periodico
Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women (2017)
Carvalho, Daniela Miarelli; Filgueira, Gabriela Campos de Oliveira; Marques, Maria Paula; Caris, Juciene Aparecida; Duarte, Geraldo; Cavalli, Ricardo de Carvalho; Lanchote, Vera Lúcia; Moisés, Elaine Christine Dantas
Source: Journal of Research Analytica. Unidades: FMRP, FCFRP
Subjects: ANTIDEPRESSIVOS, GRAVIDEZ, FARMACOCINÉTICA, LÍQUIDO AMNIÓTICO, CROMATOGRAFIA LÍQUIDA, ESPECTROMETRIA DE MASSAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARVALHO, Daniela Miarelli et al. Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women. Journal of Research Analytica, v. 3, n. 1, p. 1-9, 2017Tradução . . Disponível em: https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women. Acesso em: 03 jun. 2024.
APA
Carvalho, D. M., Filgueira, G. C. de O., Marques, M. P., Caris, J. A., Duarte, G., Cavalli, R. de C., et al. (2017). Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women. Journal of Research Analytica, 3( 1), 1-9. Recuperado de https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women
NLM
Carvalho DM, Filgueira GC de O, Marques MP, Caris JA, Duarte G, Cavalli R de C, Lanchote VL, Moisés ECD. Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women [Internet]. Journal of Research Analytica. 2017 ; 3( 1): 1-9.[citado 2024 jun. 03 ] Available from: https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women
Vancouver
Carvalho DM, Filgueira GC de O, Marques MP, Caris JA, Duarte G, Cavalli R de C, Lanchote VL, Moisés ECD. Analysis of fluoxetine and norfluoxetine enantiomers in human plasma and amniotic fluid by LC-MS/MS and its application to clinical pharmacokinetics in pregnant women [Internet]. Journal of Research Analytica. 2017 ; 3( 1): 1-9.[citado 2024 jun. 03 ] Available from: https://www.researchgate.net/publication/316844173_Analysis_of_Fluoxetine_and_Norfluoxetine_Enantiomers_in_Human_Plasma_and_Amniotic_Fluid_by_LC-MSMS_and_Its_Application_to_Clinical_Pharmacokinetics_in_Pregnant_Women
Artigo de periodico
Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism (2017)
Nardotto, Glauco H. B.; Coelho, Eduardo Barbosa; Paiva, Carlos E.; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: DIABETES MELLITUS, ANTAGONISTAS, RECEPTORES ADRENÉRGICOS, FREQUÊNCIA CARDÍACA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco H. B. et al. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 760-769, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.864. Acesso em: 03 jun. 2024.
APA
Nardotto, G. H. B., Coelho, E. B., Paiva, C. E., & Lanchote, V. L. (2017). Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, 57( 6), 760-769. doi:10.1002/jcph.864
NLM
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.864
Vancouver
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.864
Artigo de periodico
Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects (2017)
Antunes, Natalicia de Jesus; van Dijkman, Sven C.; Lanchote, Vera Lúcia; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaíti; Tozatto, Eduardo; van Hasselt, J.G. Coen; Della Pasqua, Oscar
Source: European Journal of Pharmaceutical Sciences. Unidades: FCFRP, FMRP
Assunto: ANTICONVULSIVANTES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalicia de Jesus et al. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. European Journal of Pharmaceutical Sciences, v. 109, p. S116-S123, 2017Tradução . . Disponível em: https://doi.org/10.1016/j.ejps.2017.05.034. Acesso em: 03 jun. 2024.
APA
Antunes, N. de J., van Dijkman, S. C., Lanchote, V. L., Wichert-Ana, L., Coelho, E. B., Alexandre Junior, V., et al. (2017). Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects. European Journal of Pharmaceutical Sciences, 109, S116-S123. doi:10.1016/j.ejps.2017.05.034
NLM
Antunes N de J, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Alexandre Junior V, Takayanagui OM, Tozatto E, van Hasselt JGC, Della Pasqua O. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 S116-S123.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.034
Vancouver
Antunes N de J, van Dijkman SC, Lanchote VL, Wichert-Ana L, Coelho EB, Alexandre Junior V, Takayanagui OM, Tozatto E, van Hasselt JGC, Della Pasqua O. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects [Internet]. European Journal of Pharmaceutical Sciences. 2017 ; 109 S116-S123.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.ejps.2017.05.034
Artigo de periodico
Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers (2016)
Antunes, Natalícia de Jesus; Wichert-Ana, Lauro; Coelho, Eduardo Barbosa; Pasqua, Oscar Della; Alexandre Junior, Veriano; Takayanagui, Osvaldo Massaiti; Tozatto, Eduardo; Marques, Maria Paula; Lanchote, Vera Lúcia
Source: European Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: ANTICONVULSIVANTES, FARMACOCINÉTICA CLÍNICA, MOLÉCULA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANTUNES, Natalícia de Jesus et al. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, v. 72, n. 2, p. 195-201, 2016Tradução . . Disponível em: https://doi.org/10.1007/s00228-015-1970-4. Acesso em: 03 jun. 2024.
APA
Antunes, N. de J., Wichert-Ana, L., Coelho, E. B., Pasqua, O. D., Alexandre Junior, V., Takayanagui, O. M., et al. (2016). Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers. European Journal of Clinical Pharmacology, 72( 2), 195-201. doi:10.1007/s00228-015-1970-4
NLM
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00228-015-1970-4
Vancouver
Antunes N de J, Wichert-Ana L, Coelho EB, Pasqua OD, Alexandre Junior V, Takayanagui OM, Tozatto E, Marques MP, Lanchote VL. Influence of verapamil on the pharmacokinetics of oxcarbazepine and of the enantiomers of its 10-hydroxy metabolite in healthy volunteers [Internet]. European Journal of Clinical Pharmacology. 2016 ; 72( 2): 195-201.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1007/s00228-015-1970-4
Artigo de periodico
Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain (2016)
Moraes, Natália V. de; Lauretti, Gabriela Rocha; Coelho, Eduardo Barbosa; Godoy, Ana Leonor P. C.; Neves, Daniel V.; Lanchote, Vera Lúcia
Source: Fundamental and Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: ANALGÉSICOS, CITOCROMO P-450, ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORAES, Natália V. de et al. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental and Clinical Pharmacology, v. 30, n. 2, p. 153-161, 2016Tradução . . Disponível em: https://doi.org/10.1111/fcp.12168. Acesso em: 03 jun. 2024.
APA
Moraes, N. V. de, Lauretti, G. R., Coelho, E. B., Godoy, A. L. P. C., Neves, D. V., & Lanchote, V. L. (2016). Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain. Fundamental and Clinical Pharmacology, 30( 2), 153-161. doi:10.1111/fcp.12168
NLM
Moraes NV de, Lauretti GR, Coelho EB, Godoy ALPC, Neves DV, Lanchote VL. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain [Internet]. Fundamental and Clinical Pharmacology. 2016 ; 30( 2): 153-161.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/fcp.12168
Vancouver
Moraes NV de, Lauretti GR, Coelho EB, Godoy ALPC, Neves DV, Lanchote VL. Impact of fraction unbound, CYP3A, and CYP2D6 in vivo activities, and other potential covariates to the clearance of tramadol enantiomers in patients with neuropathic pain [Internet]. Fundamental and Clinical Pharmacology. 2016 ; 30( 2): 153-161.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/fcp.12168
Artigo de periodico
Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers (2016)
Neves, Daniel V.; Lanchote, Vera Lúcia; Moysés Neto, Miguel; Costa, José Abrão Cardeal da; Vieira, Carolina P.; Coelho, Eduardo Barbosa
Source: British Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: NEFROPATIAS, FARMACOCINÉTICA, FENÓTIPOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NEVES, Daniel V. et al. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, v. 82, n. 1, p. 83-91, 2016Tradução . . Disponível em: https://doi.org/10.1111/bcp.12917. Acesso em: 03 jun. 2024.
APA
Neves, D. V., Lanchote, V. L., Moysés Neto, M., Costa, J. A. C. da, Vieira, C. P., & Coelho, E. B. (2016). Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers. British Journal of Clinical Pharmacology, 82( 1), 83-91. doi:10.1111/bcp.12917
NLM
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/bcp.12917
Vancouver
Neves DV, Lanchote VL, Moysés Neto M, Costa JAC da, Vieira CP, Coelho EB. Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers [Internet]. British Journal of Clinical Pharmacology. 2016 ; 82( 1): 83-91.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1111/bcp.12917
Artigo de periodico
Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study (2016)
Nardotto, Glauco Henrique Balthazar; Coelho, Eduardo Barbosa; Marques, Maria Paula; Lanchote, Vera Lúcia
Source: Journal of Chromatography B. Unidades: FMRP, FCFRP
Subjects: ESPECTROMETRIA DE MASSAS, REPRODUTIBILIDADE DE RESULTADOS, CROMATOGRAFIA LÍQUIDA, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NARDOTTO, Glauco Henrique Balthazar et al. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study. Journal of Chromatography B, v. 1015, p. 173-180, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2016.02.028. Acesso em: 03 jun. 2024.
APA
Nardotto, G. H. B., Coelho, E. B., Marques, M. P., & Lanchote, V. L. (2016). Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study. Journal of Chromatography B, 1015, 173-180. doi:10.1016/j.jchromb.2016.02.028
NLM
Nardotto GHB, Coelho EB, Marques MP, Lanchote VL. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1015 173-180.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jchromb.2016.02.028
Vancouver
Nardotto GHB, Coelho EB, Marques MP, Lanchote VL. Chiral analysis of carvedilol and its metabolites hydroxyphenyl carvedilol and O-desmethyl carvedilol in human plasma by liquid chromatography-tandem mass spectrometry: application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1015 173-180.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jchromb.2016.02.028
Artigo de periodico
Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics (2016)
Silva, Carolina de Miranda; Rocha, Adriana; Tozatto, Eduardo; Silva, Lucienir Maria da; Donadi, Eduardo Antônio; Lanchote, Vera Lúcia
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidades: FCFRP, FMRP
Subjects: MOLÉCULA, ANTI-INFLAMATÓRIOS, FARMACOCINÉTICA, PLASMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carolina de Miranda et al. Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, v. 120, p. 120-126, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jpba.2015.12.009. Acesso em: 03 jun. 2024.
APA
Silva, C. de M., Rocha, A., Tozatto, E., Silva, L. M. da, Donadi, E. A., & Lanchote, V. L. (2016). Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics. Journal of Pharmaceutical and Biomedical Analysis, 120, 120-126. doi:10.1016/j.jpba.2015.12.009
NLM
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Lanchote VL. Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2016 ; 120 120-126.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jpba.2015.12.009
Vancouver
Silva C de M, Rocha A, Tozatto E, Silva LM da, Donadi EA, Lanchote VL. Enantioselective analysis of etodolac in human plasma by LC–MS/MS: application to clinical pharmacokinetics [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2016 ; 120 120-126.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jpba.2015.12.009
Artigo de periodico
Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study (2016)
Castro, Francine Attié de; Scatena, Gabriel dos Santos; Rocha, Otávio Pelegrino; Marques, Maria Paula; Cass, Quézia Bezerra; Simões, Belinda Pinto; Lanchote, Vera Lúcia
Source: Journal of Chromatography B. Unidades: FMRP, FCFRP
Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA PRESSÃO, ESPECTROMETRIA DE MASSAS, REPRODUTIBILIDADE DE RESULTADOS, FARMACOCINÉTICA, REGRESSÃO LINEAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study. Journal of Chromatography B, v. 1011, p. 53-61, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.jchromb.2015.12.049. Acesso em: 03 jun. 2024.
APA
Castro, F. A. de, Scatena, G. dos S., Rocha, O. P., Marques, M. P., Cass, Q. B., Simões, B. P., & Lanchote, V. L. (2016). Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study. Journal of Chromatography B, 1011, 53-61. doi:10.1016/j.jchromb.2015.12.049
NLM
Castro FA de, Scatena G dos S, Rocha OP, Marques MP, Cass QB, Simões BP, Lanchote VL. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1011 53-61.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jchromb.2015.12.049
Vancouver
Castro FA de, Scatena G dos S, Rocha OP, Marques MP, Cass QB, Simões BP, Lanchote VL. Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study [Internet]. Journal of Chromatography B. 2016 ; 1011 53-61.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1016/j.jchromb.2015.12.049
Artigo de periodico
Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients (2016)
Godoy, Ana Leonor Pardo Campos; Rocha, Adriana; Souza, Cacilda da Silva; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FCFRP, FMRP
Subjects: METABOLISMO, FARMACOCINÉTICA, PSORÍASE, ANTIDEPRESSIVOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GODOY, Ana Leonor Pardo Campos et al. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, v. 56, n. 5, p. 567-575, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.630. Acesso em: 03 jun. 2024.
APA
Godoy, A. L. P. C., Rocha, A., Souza, C. da S., & Lanchote, V. L. (2016). Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients. The Journal of Clinical Pharmacology, 56( 5), 567-575. doi:10.1002/jcph.630
NLM
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.630
Vancouver
Godoy ALPC, Rocha A, Souza C da S, Lanchote VL. Pharmacokinetics of venlafaxine enantiomers and their metabolites in psoriasis patients [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 5): 567-575.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.630
Artigo de periodico
Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine (2016)
Castro, Francine Attié de; Simões, Belinda Pinto; Godoy, Ana Leonor Pardo Campos; Trigo, Fernanda Manuela Bertagnoli; Coelho, Eduardo Barbosa; Lanchote, Vera Lúcia
Source: The Journal of Clinical Pharmacology. Unidades: FMRP, FCFRP
Subjects: CÉLULAS-TRONCO, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, Francine Attié de et al. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, v. 56, n. 12, p. 1555-1562, 2016Tradução . . Disponível em: https://doi.org/10.1002/jcph.758. Acesso em: 03 jun. 2024.
APA
Castro, F. A. de, Simões, B. P., Godoy, A. L. P. C., Trigo, F. M. B., Coelho, E. B., & Lanchote, V. L. (2016). Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine. The Journal of Clinical Pharmacology, 56( 12), 1555-1562. doi:10.1002/jcph.758
NLM
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.758
Vancouver
Castro FA de, Simões BP, Godoy ALPC, Trigo FMB, Coelho EB, Lanchote VL. Use of an oral busulfan test dose in patients undergoing hematopoietic stem cell transplantation treated with or without fludarabine [Internet]. The Journal of Clinical Pharmacology. 2016 ; 56( 12): 1555-1562.[citado 2024 jun. 03 ] Available from: https://doi.org/10.1002/jcph.758

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration

Sigla do Departamento/Programa de Pós Graduação